Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

China Biologic Produ (CBPO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,926,753
  • Shares Outstanding, K 39,362
  • Annual Sales, $ 466,880 K
  • Annual Income, $ 128,060 K
  • 60-Month Beta 1.26
  • Price/Sales 8.28
  • Price/Cash Flow 19.23
  • Price/Book 1.76

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.99
  • Number of Estimates 2
  • High Estimate 1.01
  • Low Estimate 0.96
  • Prior Year 1.21
  • Growth Rate Est. (year over year) -18.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.85 +14.86%
on 03/25/19
99.90 -0.14%
on 04/24/19
+12.53 (+14.36%)
since 03/22/19
3-Month
76.50 +30.41%
on 02/07/19
99.90 -0.14%
on 04/24/19
+19.76 (+24.70%)
since 01/24/19
52-Week
60.08 +66.05%
on 10/26/18
107.44 -7.15%
on 07/10/18
+15.88 (+18.93%)
since 04/24/18

Most Recent Stories

More News
First Week of May 17th Options Trading For China Biologic Products Holdings (CBPO)

Investors in China Biologic Products Holdings Inc saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...

CBPO : 99.76 (+1.60%)
New Strong Sell Stocks for April 9th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

CBPO : 99.76 (+1.60%)
AMEH : 19.52 (+0.62%)
CCRN : 7.10 (+0.85%)
BIOS : 1.85 (+1.09%)
CNTY : 9.04 (+0.78%)
New Strong Sell Stocks for April 4th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

GWRS : 9.75 (-0.31%)
CBPO : 99.76 (+1.60%)
FTD : 0.46 (unch)
CZR : 9.46 (-0.11%)
CNTY : 9.04 (+0.78%)
New Strong Sell Stocks for March 22nd

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

BUD : 88.21 (-1.17%)
AEIS : 58.82 (+2.92%)
CBPO : 99.76 (+1.60%)
AMC : 15.44 (+1.25%)
AEM : 40.60 (+1.17%)
New Strong Sell Stocks for March 20th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

GWRS : 9.75 (-0.31%)
CBPO : 99.76 (+1.60%)
DGICA : 13.31 (-0.22%)
GPX : 12.55 (+2.62%)
GSBD : 20.62 (-0.72%)
New Strong Sell Stocks for March 18th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

AEIS : 58.82 (+2.92%)
CBPO : 99.76 (+1.60%)
AMC : 15.44 (+1.25%)
BMRN : 85.49 (-0.59%)
CWST : 36.42 (+1.34%)
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018

4Q18 Total Sales Up 27.5% YoY in USD terms, or 33.5% YoY in RMB terms; Net Income Up $59.4 Million YoY to $34.8 Million; Non-GAAP Adjusted Net Income Up 23.9% YoY in RMB terms --

CBPO : 99.76 (+1.60%)
China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results

China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans...

CBPO : 99.76 (+1.60%)
China Biologic Reiterates Full Year 2018 Financial Forecast

China Biologic Products Holdings, Inc. (NASDAQ: CBPO)("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today reiterated its previously revised...

CBPO : 99.76 (+1.60%)
China Biologic Products: 1Q Earnings Snapshot

BEIJING (AP) _ China Biologic Products Inc. (CBPO) on Friday reported first-quarter earnings of $31.6 million.

CBPO : 99.76 (+1.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade CBPO with:

Business Summary

China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological...

See More

Key Turning Points

2nd Resistance Point 101.51
1st Resistance Point 100.63
Last Price 99.76
1st Support Level 98.15
2nd Support Level 96.55

See More

52-Week High 107.44
Last Price 99.76
Fibonacci 61.8% 89.35
Fibonacci 50% 83.76
Fibonacci 38.2% 78.17
52-Week Low 60.08

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar